Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study

Nai Jung Chiang, Kien Thiam Tan, Li Yuan Bai, Chin Fu Hsiao, Chung Yu Huang, Yi Ping Hung, Chien Jui Huang, San Chi Chen, Yan Shen Shan, Yee Chao, Yi Hsiang Huang, I. Cheng Lee, Pei Chang Lee, Yung Yeh Su, Shu Jen Chen, Chun Nan Yeh, Li Tzong Chen, Ming Huang Chen

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study'. Together they form a unique fingerprint.

Medicine & Life Sciences